These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38280477)

  • 1. Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine.
    Shin D; Lee J; Roh JL
    Cancer Lett; 2024 Mar; 585():216645. PubMed ID: 38280477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis as a p53-mediated activity during tumour suppression.
    Jiang L; Kon N; Li T; Wang SJ; Su T; Hibshoosh H; Baer R; Gu W
    Nature; 2015 Apr; 520(7545):57-62. PubMed ID: 25799988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses.
    Jiang L; Hickman JH; Wang SJ; Gu W
    Cell Cycle; 2015; 14(18):2881-5. PubMed ID: 26218928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.
    Tarangelo A; Magtanong L; Bieging-Rolett KT; Li Y; Ye J; Attardi LD; Dixon SJ
    Cell Rep; 2018 Jan; 22(3):569-575. PubMed ID: 29346757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53.
    Wang Y; Yang L; Zhang X; Cui W; Liu Y; Sun QR; He Q; Zhao S; Zhang GA; Wang Y; Chen S
    EMBO Rep; 2019 Jul; 20(7):e47563. PubMed ID: 31267712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis.
    Gnanapradeepan K; Basu S; Barnoud T; Budina-Kolomets A; Kung CP; Murphy ME
    Front Endocrinol (Lausanne); 2018; 9():124. PubMed ID: 29695998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
    Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
    Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
    Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
    J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53: A double-edged sword in tumor ferroptosis.
    Ji H; Wang W; Li X; Han X; Zhang X; Wang J; Liu C; Huang L; Gao W
    Pharmacol Res; 2022 Mar; 177():106013. PubMed ID: 34856333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 together with ferroptosis: a promising strategy leaving cancer cells without escape.
    Zhan J; Wang J; Liang Y; Zeng X; Li E; Wang H
    Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):1-14. PubMed ID: 38105650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis.
    Gnanapradeepan K; Indeglia A; Stieg DC; Clarke N; Shao C; Dougherty JF; Murali N; Murphy ME
    J Biol Chem; 2022 Dec; 298(12):102637. PubMed ID: 36309086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 in ferroptosis regulation: the new weapon for the old guardian.
    Liu Y; Gu W
    Cell Death Differ; 2022 May; 29(5):895-910. PubMed ID: 35087226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoglobin promotes sensitivity to ferroptosis by regulating p53-YAP1 axis in colon cancer cells.
    Ye S; Xu M; Zhu T; Chen J; Shi S; Jiang H; Zheng Q; Liao Q; Ding X; Xi Y
    J Cell Mol Med; 2021 Apr; 25(7):3300-3311. PubMed ID: 33611811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor protein p53 and the ferroptosis network.
    Kang R; Kroemer G; Tang D
    Free Radic Biol Med; 2019 Mar; 133():162-168. PubMed ID: 29800655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
    Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
    Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-491-5p regulates the susceptibility of glioblastoma to ferroptosis through TP53.
    Jie XF; Li YP; Liu S; Fu Y; Xiong YY
    Biochem Biophys Res Commun; 2023 Sep; 671():309-317. PubMed ID: 37327702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression.
    Chen D; Tavana O; Chu B; Erber L; Chen Y; Baer R; Gu W
    Mol Cell; 2017 Oct; 68(1):224-232.e4. PubMed ID: 28985506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt3 is critical for p53-mediated ferroptosis upon ROS-induced stress.
    Jin Y; Gu W; Chen W
    J Mol Cell Biol; 2021 May; 13(2):151-154. PubMed ID: 33377976
    [No Abstract]   [Full Text] [Related]  

  • 20. Ferroptosis in liver diseases: Fundamental mechanism and clinical implications.
    Lai MS; Yan XP; Branch DR; Loriamini M; Chen LM
    World J Gastroenterol; 2024 Aug; 30(32):3730-3738. PubMed ID: 39221065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.